Sign inJoin waitlistJoin the waitlist

Paul Wise

Vice Chair for Education, Department of Surgery · Washington University/B-JH/SLCH Consortium

Credentials: · · · · ·

History

Department of Surgery · Washington University/B-JH/SLCH Consortium
Present
Washington University/B-JH/SLCH Consortium · Washington Univ Sch of Med
Present

Colon and Rectal Surgery
2003–2004
Surgery
1996–2003
Johns Hopkins Univ Sch of Med
1992–1996

Research

Serrated lesions of the colorectum: review and recommendations from an expert panel
The American Journal of Gastroenterology · 2012 · 878 citations
Readiness of US General Surgery Residents for Independent Practice
Annals of Surgery · 2017 · 282 citations
The Feasibility of Real-Time Intraoperative Performance Assessment With SIMPL (System for Improving and Measuring Procedural Learning): Early Experience From a Multi-institutional…
Review · Journal of surgical education · 2016 · 184 citations

Matthew Mutch
30 papers
Steven Hunt
29 papers
Matthew Silviera
28 papers · 1 as a fellow
SG
Sean Glasgow
21 papers
WC
William Chapman
19 papers
David Schwartz
14 papers
Radhika Smith
14 papers
Alan Herline
13 papers
Michael Awad
13 papers · 2 as a fellow
Roberta Muldoon
12 papers
Alexander Hawkins
11 papers · 4 as a fellow
Katharine Caldwell
11 papers · 7 as a resident

Grants

Cold Ischemia and Intracellular Calcium Release Channels
National Institute of Diabetes and Digestive and Kidney Diseases · F32
Contact PI · $79.3K · Vanderbilt University
1999

Clinical trials

Collecting Information From Patients and Family Members With Hereditary Colorectal Cancer Syndromes or Who Are at High Risk of Developing Colorectal Cancer
Study chair · Completed
Vanderbilt University Medical Center
2007–2017
Itraconazole in Combination With Ablation for the Prevention of Esophageal Cancer in Patients With High-risk Barrett's Esophagus
Site PI · Recruiting · Phase 2
National Cancer Institute (NCI)
2026–2030
Testing for Safety and Colorectal Cancer Preventive Effects of ONC201
Site PI · Recruiting · Phase 1
National Cancer Institute (NCI)
2025–2028
Evaluate REC-4881 in Participants With Familial Adenomatous Polyposis (FAP)
Site PI · Recruiting · Phase 1, Phase 2
Recursion Pharmaceuticals Inc.
2023–2027